(Q28239956)

1

0 references

Louisa G Mahaira

2

0 references

Sonia A Perez

3

0 references

Angelos D Gritzapis

4

0 references

Panagiota A Sotiropoulou

5

0 references

Giannis J Kavalakis

6

0 references

Aris I Antsaklis

7

0 references

Constantin N Baxevanis

8

0 references

Michael Papamichail

Journal of Biological Chemistry

9

0 references

language of work or name

English

0 references

publication date

20 May 2005

0 references

published in

0 references

volume

280

0 references

issue

20

0 references

page(s)

20086-93

0 references

cites work

Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

The insulin-like growth factor mRNA binding-protein IMP-1 and the Ras-regulatory protein G3BP associate with tau mRNA and HuD protein in differentiated P19 neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

Nuclear transit of human zipcode-binding protein IMP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

Expression of the RNA-binding protein CRD-BP in brain and non-small cell lung tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

Mammary tumor induction in transgenic mice expressing an RNA-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

The role of DNA methylation in mammalian epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

The rise and fall of genomic methylation in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

Gene silencing in mammals by small interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

Differential gene expression of human stem progenitor cells derived from early stages of in utero human hematopoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

Roles for c-Myc in self-renewal of hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

c-Myc enhances protein synthesis and cell size during B lymphocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

MYC oncogenes and human neoplastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200

Role of the insulin-like growth factor family in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410036200